Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer

Annals of Nuclear Medicine

Volumn 14, Issue 3, 2000, Pages 173-179

  Hosono, Masako N ^e   Hosono, Makoto ^d   Mishra, Anil K ^a   Faivre Chauvet, Alain ^a   Gautherot, Emmanuel ^b   Barbet, Jacques ^b   Knapp Jr , F F ^c   Chatal, Jean François ^a  

^a INSERM   (France)

^b Immunotech   (France)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e NONE

Author keywords

2 iminothiolane; Monoclonal antibody; Neural cell adhesion molecule; Rhenium 188; Small cell lung cancer

Indexed keywords

IMINOTHIOL; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C 218; MONOCLONAL ANTIBODY NK 1 NBL 1; NERVE CELL ADHESION MOLECULE; RHENIUM 188; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY LABELING; ARTICLE; BINDING AFFINITY; CANCER SCINTISCANNING; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STABILITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033942649     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02987856     Document Type: Article

References (26)

1. Souhami RL, Law K. Longevity in small cell lung cancer. A report to the lung cancer subcommittee of the United Kingdom Committee for Cancer Research. Br J Cancer 61: 584-589, 1990.
2. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res 51: 676-681, 1991.
3. Hosono M, Endo K, Hosono MN, Kobayashi H, Shirato M, Sakahara H, et al. Treatment of small cell lung cancer xenografts with iodine-131-anti-neural cell molecule monoclonal antibody and evaluation of absorbed dose in tissue. J Nucl Med 35: 296-300, 1994.
4. Takahashi T, Ueda R, Song X, Nishida K, Shinzato M, Namikawa R, et al. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res 46: 4770-4775, 1986.
5. Wang SJ, Lin WY, Hsieh BT, Shen LH, Tsai ZT, Ting G, et al. Rhenium-188 sulphur colloid as a radiation synovectomy agent. Eur J Nucl Med 22: 505-507, 1995.
6. Knapp FFRJ, Beets AL, Guhlke S, Zamora PO, Bender H, Palmedo H, et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer therapy. Anticancer Research 17: 1783-1796, 1997.
7. Knapp FFJ, Beets AL, Guhlke S, Gledd KN, Marboe C, Amols H, et al. Rhenium-188 liquid-filled balloons effectively inhibit restenosis in a swine coronary overstretch model - a simple new method bridging nuclear medicine and interventional cardiology. J Nucl Med 39: 48P, 1998.
8. 99mTc-labeled monoclonal antiboy. Nucl Med Biol 20: 617-623, 1993.
9. Griffiths GL, Goldenberg DM, Knapp FFJ, Callahan AP, Chang CH, Hansen HJ. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Cancer Res 51: 4594-4602, 1991.
10. Hosono MN, Hosono M, Zamora PO, Guhlke S, Haberberger T, Bender H, et al. Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice. Ann Nucl Med 12: 83-88, 1998.
11. 186Re-labeled NR-LU-10 whole antibody in LS174T colonie tumor-bearing mice. Cancer Res 50: 7973-7978, 1990.
12. Visser GWM, Gerretsen M, Herscheid JDM, Snow GB, van Dongen G. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer, a technical protocol. J Nucl Med 34: 1953-1963, 1993.
13. McCall MJ, Diril H, Meares CF. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjugate Chemistry 1: 222-226, 1990.
14. Srivastava SC, Mease RC. Progress in research on ligands, nuclides, and techniques for labeling monoclonal antibodies. Nucl Med Biol 18: 589-603, 1991.
15. 99mTc by derivatization with 1-imino-4-mercaptobutyl groups. In Technetium and Rhenium in Chemistry and Nuclear Medicine, Nicolini M, Bandoli G and Mazzi U (eds.), New York, Raven Press, pp. 595-603, 1990.
16. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK cells). Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specifies. J Exp Med 178: 597-604, 1993.
17. Moolenaar CECK, Muller EJ, Schol DJ, Figdor CG, Bock E, Bitter-Suermann D, et al. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP- 212. Cancer Res 50: 1102-1106, 1990.
18. Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331-1337, 1981.
19. Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PAJ, et al. Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res 40: 3502-3507, 1980.
20. Knapp FFRJ, Mirzadeh S. The continuing important role of radionuclide generator systems for nuclear medicine. Eur J Nucl Med 21: 1151-1165, 1994.
21. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672, 1949.
22. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibody by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72: 77-89, 1984.
23. Le Doussal J, Gruaz-Guyon A, Martin M, Delaage M, Barbet J. Targeting of indium-111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res 50: 3445-3452, 1990.
24. Hosono M, Hosono MN, Kraeber-Bodere F, Devys A, Thédrez P, Fiche M, et al. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten. J Nucl Med 39: 1608-1613, 1998.
25. Hosono M, Hosono MN, Kraeber-Bodere F, Devys A, Thédrez P, Faivre-Chauvet A, et al. Two-step targeting and dosimetry for small-cell lung cancer xenograft with anti-NCAM/anti-histamine bispecific antibody and radio-iodinated bivalent hapten. J Nucl Med 40: 1216-1221, 1999.
26. Fujimori K, Covell DG, Fletcher JE, Weinstein JN. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med 31: 1191-1198, 1990.